A man who was given a stay of less than a year is a new illness, thanks to Britain’s new chemistry regime court.
Robert Glyn, 21, said he “wouldn’t be here” if the Christi Foundation Trust trial in Manchester had not produced such good governance.
Mr Glynn, a trader from Worsley, Greater Manchester, was diagnosed in August 2021 with a fatal type of cholangiocarcinoma from the liver.
He was told it had spread to the adrenal cortex. He was given an immunotherapy drug previously approved for use in other types of cancer, along with a chemotherapy drug.
Due to the unpredictable nature of the test, the substance cannot be named. Mr. Glynn’s cancer was in remission and he underwent a mastectomy in March.
His 3 scans showed he was cancer-free. ‘My partner Simon and I go for a walk in nature. When something like this happens, you realize that life is for living.’
Categories: Trends
Source: HIS Education